Negative Gating Modulation by (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) Depends on Residues in the Inner Pore Vestibule: Pharmacological Evidence of Deep-Pore Gating of KCa2 Channels
- 1 March 2011
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 79 (6), 899-909
- https://doi.org/10.1124/mol.110.069807
Abstract
Acting as a negative gating modulator, (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) shifts the apparent Ca2+-dependence of the small-conductance Ca2+-activated K+ channels KCa2.1–2.3 to higher Ca2+ concentrations. Similar to the positive KCa channel-gating modulators 1-ethyl-2-benzimidazolinone (1-EBIO) and cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methylpyrimidin-4-yl]-amine (CyPPA), the binding site for NS8593 has been assumed to be located in the C-terminal region, in which these channels interact with their Ca2+ sensor calmodulin. However, by using a progressive chimeric approach, we were able to localize the site-of-action of NS8593 to the KCa2 pore. For example, when we transferred the C terminus from the NS8593-insensitive intermediate-conductance KCa3.1 channel to KCa2.3, the chimeric channel remained as sensitive to NS8593 as wild-type KCa2.3. In contrast, when we transferred the KCa2.3 pore to KCa3.1, the channel became sensitive to NS8593. Using site-directed mutagenesis, we subsequently identified two specific residues in the inner vestibule of KCa2.3 (Ser507 and Ala532) that determined the effect of NS8593. Mutation of these residues to the corresponding residues in KCa3.1 (Thr250 and Val275) made KCa2.3 insensitive to NS8593, whereas introduction of serine and alanine into KCa3.1 was sufficient to render this channel highly sensitive to NS8593. It is noteworthy that the same two residue positions have been found previously to mediate sensitivity of KCa3.1 to clotrimazole and 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34). The location of Ser507 in the pore-loop near the selectivity filter and Ala532 in an adjacent position in S6 are within the region predicted to contain the KCa2 channel gate. Hence, we propose that NS8593-mediated gating modulation occurs via interaction with gating structures at a position deep within the inner pore vestibule.This publication has 42 references indexed in Scilit:
- Allosteric Block of KCa2 Channels by ApaminJournal of Biological Chemistry, 2010
- Small conductance calcium-activated potassium channels: From structure to functionProgress in Neurobiology, 2010
- The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain siteNeuroscience Letters, 2009
- EF hands at the N-lobe of calmodulin are required for both SK channel gating and stable SK–calmodulin interactionThe Journal of general physiology, 2009
- Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a New Activator of KCa2 and KCa3.1 Potassium Channels, Potentiates the Endothelium-Derived Hyperpolarizing Factor Response and Lowers Blood PressureMolecular Pharmacology, 2008
- Preliminary SAR studies on non-apamin-displacing 4-(aminomethylaryl)pyrrazolopyrimidine KCa channel blockersBioorganic & Medicinal Chemistry Letters, 2008
- Evidence for a Deep Pore Activation Gate in Small Conductance Ca2+-activated K+ ChannelsThe Journal of general physiology, 2007
- Selective positive modulation of the SK3 and SK2 subtypes of small conductance Ca2+‐activated K+ channelsBritish Journal of Pharmacology, 2007
- Structural Determinants of the Closed KCa3.1 Channel Pore in Relation to Channel Gating: Results from a Substituted Cysteine Accessibility AnalysisThe Journal of general physiology, 2007
- Ca2+-activated K+ channels: molecular determinants and function of the SK familyNature Reviews Neuroscience, 2004